In vitro screening of probiotic characteristics of some italian products

Journal of Chemotherapy

Volumn 20, Issue 3, 2008, Pages 341-347

  De Vecchi, E ^a   Nicola, L ^a   Zanini, S ^a   Drago, L ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Laboratory of Microbiology LITA   (Italy)

Author keywords

Bacterial adherence; Bile tolerance; Probiotics

Indexed keywords

CODEX; DICOFLOR; ENTEROGERMINA; ENTEROLACTIS; PROBIOTIC AGENT; REUFLOR; REUTERIN; ZIRFOS;

ACID TOLERANCE; ARTICLE; BACILLUS CLAUSII; BACTERIAL CELL; BACTERIAL SPORE; BACTERIUM ADHERENCE; BIFIDOBACTERIUM LONGUM; BILE TOLERANCE; CELL STRAIN CACO 2; DRUG CAPSULE; DRUG STABILITY; DRUG STORAGE; HUMAN; HUMAN CELL; INTESTINE CELL; ITALY; LACTOBACILLUS CASEI; LACTOBACILLUS REUTERI; NONHUMAN; PH; SACCHAROMYCES BOULARDII; SCREENING;

EID: 47349129157     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.3.341     Document Type: Article

References (34)

1. FAO/WHO. (2002) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Available at: http://www.who.int/foodsafety/publications/fs_management/en/ probiotics.pdf.
2. Saavedra JM. Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects. Nutr Clin Pract. 2007; 22: 351-65.
3. Santosa S, Farnworth E, Lones PJH. Probiotics and their potential health claims. Nutr Rev 2006; 64: 265-74.
4. Isakow W, Morrow LE, Kollef MH. Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations. Chest. 2007; 132: 286-94.
5. Sheil B, Shanahan F, O'Mahony L. Probiotic effects on inflammatory bowel disease. J Nutr 2007; 137: 819S-24S.
6. Yan F, Polk DB. Probiotics as functional food in the treatment of diarrhea. Curr Opin Clin Nutr Metab Care 2006; 9: 717-21.
7. Hamilton-Miller J, Shah S. Deficiencies in microbiological quality and labelling of probiotic supplements. Int J Food Microbiol 2002; 72: 175-176.
8. Temmerman R, Pot B, Huys G, Swings J. Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol 2003; 81:1-10
9. Weese JS. Evaluation of deficiencies in labelling of commercial products. Can Vet J 2003; 44: 982-3.
10. Fasoli S, Marzotto M, Rizzotti L, Rossi F, Dellaglio F, Torriani S. Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int J Food Microbiol 2003;. 82: 59-70.
11. Huys G, Vancannyet M, D'Haene K, Vankerckhoven V, Goossens H, Swings J. Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use. Res Microbiol 2006; 137: 803-10.
12. Lin WH, Hwang CF, Chen LW, Tsen HY. Viable counts, characteristic evaluation for commercial lactic acid bacteria products. Food Microbiology 2006; 23: 74-81.
13. Reid G. The importance of guidelines in the development and application of probiotics. Curr Pharm Des 2005; 11: 11-6.
14. von Wright A. Regulating the safety of probiotics. The European approach. Curr Pharm Des 2005; 11: 17-23.
15. Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuewenhoek 2002; 82, 279-89.
16. Salminen S, Laine M, von Wright A, Vuopio-Varkila J, Korhonen T, Mattila-Sandholm T. Development of selection criteria for probiotic strains to assess their potential in functional foods: a Nordic and European approach. Biosci Microflora 1996; 15: 61-7.
17. Saxelin M. Probiotic Formulations and Applications, the Current Probiotics Market, and Changes in the Marketplace: A European Perspective. Clin Infect Dis 2008; 46: S76-9
18. Hamilton-Miller JMT, Shah S, Winkler JT. Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganims. Public Health Nutrition 1999; 2: 223-229.
19. Coeuret V, Gueguen M, Vernoux JP. Numbers and strains of lactobacilli in some probiotic products. Int J Food Microbiol. 2004; 97: 147-56.
20. Drago L, De Vecchi E, Nicola L, Colombo A, Gismondo MR. Microbiological evaluation of commercial probiotic products available in Italy. J Chemother. 2004; 16: 463-7
21. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr. 2001; 73(Suppl 2):386S-392S.
22. Hofmann AF, Mysels KJ. Bile acid solubility and precipitation in vitro and in vivo: the role of conjugation, pH and Ca2+ ions. J Lipid Res 1992; 33: 617-26.
23. De Boever P, Verstraete W. Bile salt deconjugation by Lactobacillus plantarum 80 and its implication for bacterial toxicity. J Appl Microbiol 1999; 87: 345-52.
24. Guo X, Li D, Lu W, Piao X, Chen X. Screening of Bacillus strains as potential probiotics and subsequent confirmation of the in vivo effectiveness of Bacillus subtilis MA139 in pigs. Antonie van Leeuwenhoek 2006; 90: 139-46.
25. Due LH, Hong HA, Barbosa T, Henriques AO, Cutting SM. Characterization of Bacillus probiotics available for human use. Appl Environ Microbiol 2004; 70: 2161-71.
26. Casula G, Cutting SM. Bacillus probiotics: spore germination in the gastrointestinal tract. Appl Environ Microbiol 2002; 68: 2344-52.
27. Kheadr E, Dabour N, Le Lay C, Lacroix C, Fliss I. Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress. Antimicrob Agents Chemother. 2007; 51: 169-74.
28. Charteris WP, Kelly PM, Morelli L, Collins JK. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiol 1998, 84: 759-68.
29. Vernazza CL, Gibson GR, Rastall RA. Carbohydrate preference, acid tolerance and bile tolerance in five strains of Bifidobacterium. J Appl Microbiol. 2006;100(4):846-53.
30. Fernández MF, Boris S, Barbés C. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J Appl Microbiol 2003; 94: 449-455
31. Ouwehand AC, Salminen S. In vitro adhesion assays for probiotics and their in vivo relevance: a review. Microb Ecol Health Dis 2003; 15: 175-84.
32. Schiffrin EJ, Brassard D, Servin AL, Rochat F, Donnet-Hughes A. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 1997; 66: 515-20.
33. Crociani J, Grill JP, Huppert M, Ballongue J. Adhesion of different bifidobacteria strains to human enterocyte-like Caco2 cells and comparison with in vivo study. Lett Appl Microbiol 1995; 21: 146-48.
34. Edwards-Ingram L, Gitsham P, Burton N, Warhurst G, Clarke I, Hoyle D, Oliver SG, Stateva L. Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Appl Environ Microbiol. 2007; 73: 2458-67.